In SLE, there is an altered distribution of T lymphocyte subpopulations, decreased production of IL-2, an increase in the pro-inflammatory cytokines IL-6, IL-17 and BAFF/BLyS, and a decrease in regulatory T lymphocytes. Here, IL17A is linked to systemic lupus erythematosus.